197 related articles for article (PubMed ID: 34008252)
1. Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study.
Martinez M; Perito ER; Valentino P; Mack CL; Aumar M; Broderick A; Draijer LG; Fagundes EDT; Furuya KN; Gupta N; Horslen S; Jonas MM; Kamath BM; Kerkar N; Kim KM; Kolho KL; Koot BGP; Laborda TJ; Lee CK; Loomes KM; Miloh T; Mogul D; Mohammed S; Ovchinsky N; Rao G; Ricciuto A; Rodrigues Ferreira A; Schwarz KB; Smolka V; Tanaka A; Tessier MEM; Venkat VL; Vitola BE; Woynarowski M; Zerofsky M; Deneau MR
Hepatology; 2021 Oct; 74(4):2047-2057. PubMed ID: 34008252
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study.
Visseren T; Erler NS; Heimbach JK; Eaton JE; Selzner N; Gulamhusein A; van der Heide F; Porte RJ; van Hoek B; Alwayn IPJ; Metselaar HJ; IJzermans JNM; Darwish Murad S
JHEP Rep; 2022 Dec; 4(12):100599. PubMed ID: 36426376
[TBL] [Abstract][Full Text] [Related]
4. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with
Bajer L; Slavcev A; Macinga P; Sticova E; Brezina J; Roder M; Janousek R; Trunecka P; Spicak J; Drastich P
World J Gastroenterol; 2018 Nov; 24(43):4939-4949. PubMed ID: 30487703
[TBL] [Abstract][Full Text] [Related]
6. Pediatric liver transplantation for primary sclerosing cholangitis.
Miloh T; Anand R; Yin W; Vos M; Kerkar N; Alonso E;
Liver Transpl; 2011 Aug; 17(8):925-33. PubMed ID: 21506253
[TBL] [Abstract][Full Text] [Related]
7. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
[TBL] [Abstract][Full Text] [Related]
8. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis.
Martin EF; Levy C
Semin Liver Dis; 2017 Nov; 37(4):305-313. PubMed ID: 29272893
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
Ravikumar R; Tsochatzis E; Jose S; Allison M; Athale A; Creamer F; Gunson B; Iyer V; Madanur M; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A
J Hepatol; 2015 Nov; 63(5):1139-46. PubMed ID: 26186988
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
[TBL] [Abstract][Full Text] [Related]
11. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
Brandsaeter B; Schrumpf E; Bentdal O; Brabrand K; Smith HJ; Abildgaard A; Clausen OP; Bjoro K
Liver Transpl; 2005 Nov; 11(11):1361-9. PubMed ID: 16184522
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
Visseren T; Erler NS; Polak WG; Adam R; Karam V; Vondran FWR; Ericzon BG; Thorburn D; IJzermans JNM; Paul A; van der Heide F; Taimr P; Nemec P; Pirenne J; Romagnoli R; Metselaar HJ; Darwish Murad S;
Transpl Int; 2021 Aug; 34(8):1455-1467. PubMed ID: 34028110
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis.
Mammadov RA; Selten JW; Roest HP; Verhoeven CJ; Maroni L; Bril SI; Tolenaars D; Gadjradj PS; van de Graaf SFJ; Oude Elferink RPJ; Kwekkeboom J; Metselaar HJ; Peppelenbosch MP; Beuers U; IJzermans JNM; van der Laan LJW
Transplantation; 2023 Aug; 107(8):1764-1775. PubMed ID: 36978227
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
Cholongitas E; Shusang V; Papatheodoridis GV; Marelli L; Manousou P; Rolando N; Patch D; Rolles K; Davidson B; Burroughs AK
Liver Transpl; 2008 Feb; 14(2):138-43. PubMed ID: 18236447
[TBL] [Abstract][Full Text] [Related]
15. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data.
Catanzaro E; Gringeri E; Cazzagon N; Floreani A; Cillo U; Burra P; Gambato M
J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38540965
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis - a propensity score-matched intention-to-treat analysis.
Åberg F; Sallinen V; Tuominen S; Adam R; Karam V; Mirza D; Heneghan MA; Line PD; Bennet W; Ericzon BG; Grat M; Lodge P; Rasmussen A; Schmelzle M; Thorburn D; Fondevila C; Helanterä I; Nordin A;
J Hepatol; 2024 Jan; 80(1):99-108. PubMed ID: 37722533
[TBL] [Abstract][Full Text] [Related]
18. Post-Transplant Disease Recurrence in Pediatric PSC.
Soufi N; Bazerbachi F; Deneau M
Curr Gastroenterol Rep; 2018 Aug; 20(9):44. PubMed ID: 30083892
[TBL] [Abstract][Full Text] [Related]
19. The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.
Moncrief KJ; Savu A; Ma MM; Bain VG; Wong WW; Tandon P
Can J Gastroenterol; 2010 Jan; 24(1):40-6. PubMed ID: 20186355
[TBL] [Abstract][Full Text] [Related]
20. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
Hole MJ; Jørgensen KK; Holm K; Braadland PR; Meyer-Myklestad MH; Medhus AW; Reikvam DH; Götz A; Grzyb K; Boberg KM; Karlsen TH; Kummen M; Hov JR
Hepatology; 2023 Mar; 77(3):715-728. PubMed ID: 36056902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
